Alsaleh Ahmed, Alfarhan Abdulrahman
Anterior Segment Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Middle East Afr J Ophthalmol. 2024 Jan 22;30(1):55-58. doi: 10.4103/meajo.meajo_33_23. eCollection 2023 Jan-Mar.
5-fluorouracil (5-FU) is an important chemotherapy adjunct for the management of conjunctival and corneal dysplasia. Since it is possible for this agent to gain access to the anterior chamber, several reports in the literature have demonstrated 5-FU long-term safety and efficacy. Although recent publications reported that topical 5-FU has no cytotoxic effect on the corneal endothelium, we report a patient affected by bilateral ocular surface squamous neoplasia who has developed significant endothelial density and morphology changes after starting a course of 5-FU.
5-氟尿嘧啶(5-FU)是治疗结膜和角膜发育异常的重要化疗辅助药物。由于该药物有可能进入前房,文献中的几篇报道已证实了5-FU的长期安全性和有效性。尽管最近的出版物报道局部应用5-FU对角膜内皮没有细胞毒性作用,但我们报告了一名双侧眼表鳞状细胞瘤患者,在开始使用一个疗程的5-FU后出现了明显的内皮密度和形态变化。